First Trust Health Care AlphaDEX® Fund(FXH)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
3-STAR RATING
STRONG BUY
BUY for 18 days
PROFIT SINCE LAST BUY
+2.5% ▲
LAST CLOSE
$138.21
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for FXH

11/13/2026: FXH (3-star) is a STRONG-BUY. BUY for 18 days. Simulated Profits (2.50%). Updated daily EoD!

FXH provides targeted exposure to the US healthcare sector using the proprietary AlphaDEX quantitative methodology to select stocks based on growth and value metrics. Its primary strength lies in this systematic, factor-based approach, which differentiates it from standard market-cap-weighted sector funds. Investors typically use it as a strategic sector tilt within a broader portfolio. Key risks include sector-specific regulatory and pricing pressures, as well as the potential for the factor strategy to underperform in certain market conditions. It is best suited for long-term investors who believe in the healthcare sector's growth potential and prefer a quantitative, rules-based selection strategy over passive indexing.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.

Investor Fit

Investor styleFitWhy
Growth investorStrong fitThe AlphaDEX methodology specifically screens for growth metrics to tilt the portfolio toward high-potential stocks.
Momentum investorStrong fit while signal remains positiveThe rules-based nature of the fund can capture momentum trends within the healthcare sector during market upturns.
Value investorStrong fitThe fund incorporates value-based screening, providing exposure to stocks that may be undervalued relative to peers.
Dividend/Income investorMixed fitWhile the fund holds healthcare stocks, its primary focus is on factor-based growth/value, not specifically high yield.
Low-risk investorWeak fitAs a sector-specific equity ETF, it is subject to higher volatility than broad-market or defensive funds.

Investor Profile

Ideal Investor Profile

Investors seeking targeted US healthcare exposure who prefer a factor-based systematic selection process over simple market-cap weighting.

Suitability

Best for long-term investors looking to tilt their portfolios toward healthcare with a goal of capturing factor-based performance.

Risk Profile

Risk factorLevelWhy it matters
VolatilityMedium / highThe concentrated nature of sector investing leads to higher price swings compared to diversified index funds.
Market riskMedium / highThe fund is fully exposed to equity market fluctuations and healthcare sector-specific developments.
ConcentrationHighRestricting investments to one sector increases the risk of negative impacts from industry-wide regulatory or economic events.
Tracking/expenseMediumThe 0.62% expense ratio is higher than plain-vanilla sector ETFs, which can impact long-term net performance.
LiquidityLowThe fund is generally liquid, but large trades could face higher costs during periods of market stress.
Business/sector qualityMediumThe healthcare sector faces ongoing risks related to drug pricing, patent cliffs, and legislative changes.

Sector & Industry Intelligence

This fund is not assigned to one sector.

Risk Analysis

Volatility

FXH experiences volatility typical of a thematic sector fund, often exacerbated by the performance swings of biotech and small-cap healthcare stocks.

Market Risk

Risks include sector-specific regulatory shifts, clinical trial outcomes, and general equity market sensitivity to interest rates and economic growth.

What the ETF Owns

Exposure TypeExposureWeight (%)Retail Investor Read
SectorUS Healthcare Equities99The fund provides concentrated exposure to the US healthcare industry using a factor-weighted selection process.
Cash/collateralCash and Cash Equivalents1A small portion of the fund is held in cash to manage daily liquidity and rebalancing needs.

Price Behavior

Strong Uptrend
PRICE PATH

Strong Uptrend

The stock has maintained a strong upward price trend across the last three quarters.

Very Smooth
PRICE STABILITY

Very Smooth

The stock has followed a highly orderly price path with minimal short-term disruption.

Analysis of Past Performance

Type ETF
Historic Profit 28.46%
Avg. Invested days 67
Today’s Advisory Strong Buy
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 4.0
ETF Returns Performance Upturn Returns Performance icon 4.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026
Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.